| Detailed information |
|---|
| CancerLivER ID | 2198 |
| Biomarker | miR-26a |
| Biomarker Name/Symbol (given in Publication) | miR-26a |
| Biomolecule | miRNA |
| Subject | Human cell line |
| Degree of Validity | Potential biomarker for HCC diagnosis; but not validated on human patient cohort |
| Experimental Condition | Normal cell line vs Liver cancer cell line |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in HepG2 cells |
| Level of significance | p < 0.05 |
| Source | Cells |
| PMID | 29430178 |
| Type of Biomarker | Potential Diagnostic * |
| Pathway | cyclin-dependent and -independent pathway |
| Cohort | The human embryonic kidney 293T (HEK293T) and huma liver cancer cell line HepG2 |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human liver cancer |
| Year of Publication | 2018 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |